Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gina Parziale"'
Autor:
Rachel Lennon, Sharon Lagas, A Neil Turner, Judith Savige, Melissa Stepney, Oliver Gross, Jeffrey H. Miner, Michelle N. Rheault, Frances Flinter, André Weinstock, Susie Gear, Gina Parziale, Michael J. Randles
Publikováno v:
Pediatric Nephrology (Berlin, Germany)
Rheault, M N, Savige, J, Randles, M J, Weinstock, A, Stepney, M, Turner, N, Parziale, G & Gross, O 2019, ' The importance of clinician, patient & researcher collaborations in Alport Syndrome ', Pediatric Nephrology . https://doi.org/10.1007/s00467-019-04241-7
Rheault, M N, Savige, J, Randles, M J, Weinstock, A, Stepney, M, Turner, A N, Parziale, G, Gross, O, Flinter, F A, Miner, J H, Lagas, S, Gear, S & Lennon, R 2019, ' The importance of clinician, patient and researcher collaborations in Alport syndrome ', Pediatric Nephrology . https://doi.org/10.1007/s00467-019-04241-7
Rheault, M N, Savige, J, Randles, M J, Weinstock, A, Stepney, M, Turner, N, Parziale, G & Gross, O 2019, ' The importance of clinician, patient & researcher collaborations in Alport Syndrome ', Pediatric Nephrology . https://doi.org/10.1007/s00467-019-04241-7
Rheault, M N, Savige, J, Randles, M J, Weinstock, A, Stepney, M, Turner, A N, Parziale, G, Gross, O, Flinter, F A, Miner, J H, Lagas, S, Gear, S & Lennon, R 2019, ' The importance of clinician, patient and researcher collaborations in Alport syndrome ', Pediatric Nephrology . https://doi.org/10.1007/s00467-019-04241-7
Alport syndrome is caused by mutations in the genes COL4A3, COL4A4 or COL4A5 and is characterised by progressive glomerular disease, sensorineural hearing loss and ocular defects. Occurring in less than 1:5000, Alport syndrome is a rare genetic disor
Autor:
B. André Weinstock, David L. Feldman, Alessia Fornoni, Oliver Gross, Clifford E. Kashtan, Sharon Lagas, Rachel Lennon, Jeffrey H. Miner, Michelle N. Rheault, James F. Simon, Lisa Bonebrake, Marty Dunleavy, Phil Kumnick, Gina Parziale, Janine Reed, André Weinstock, Susie Gear, Kristen Binaso, Raymond Manuel, James Simon, Gerald Appel, Melanie Blank, Winson Tang, Aliza Thompson, Roser Torra, Kenneth Lieberman, Christoph Licht, Karin Dahan, Kandai Nozu, Hirofumi Kai, Sharon Ricardo, Anne Pariser, David Feldman, Heather Cook, Melanie Chin, Angela Goldsberry, Colin Meyer, Lisa Anne Melia, Radko Komers, Michael Markels, Alex Mercer, Marco Prunotto, Bruce Morgenstern, Ali Hariri, Vijay Modur, Neil Turner, Clifford Kashtan, Michelle Rheault, Colin Baigent, Stephano DeSacco, Laura Perin, Moumita Barua, Koichi Nakanishi, George Jarad, Jeffrey Miner
Publikováno v:
Weinstock, B A, Feldman, D L, Fornoni, A, Gross, O, Kashtan, C E, Lagas, S, Lennon, R, Miner, J H, Rheault, M N, Simon, J F, Bonebrake, L, Dunleavy, M, Kumnick, P, Lagas, S, Parziale, G, Reed, J, Weinstock, A, Gear, S, Binaso, K, Manuel, R, Simon, J, Appel, G, Blank, M, Tang, W, Thompson, A, Torra, R, Lieberman, K, Licht, C, Dahan, K, Nozu, K, Kai, H, Ricardo, S, Pariser, A, Feldman, D, Cook, H, Chin, M, Goldsberry, A, Meyer, C, Melia, L A, Komers, R, Markels, M, Mercer, A, Prunotto, M, Morgenstern, B, Hariri, A, Modur, V, Turner, N, Gross, O, Fornoni, A, Kashtan, C, Rheault, M, Baigent, C, Desacco, S, Perin, L, Barua, M, Nakanishi, K, Jarad, G & Miner, J 2020, ' Clinical trial recommendations for potential Alport syndrome therapies ', Kidney International, vol. 97, no. 6, pp. 1109-1116 . https://doi.org/10.1016/j.kint.2020.02.029
Alport syndrome is experiencing a remarkable increase in preclinical investigations. To proactively address the needs of the Alport syndrome community, as well as offer clarity for future clinical research sponsors, the Alport Syndrome Foundation hos